Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Papillomavirus Infections × Diphtheria Toxoid × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 1 Human Papillomavirus-Related Cervical Carcinoma 1

Interventions

Human Papillomavirus Recombinant Vaccine nonavalent 7 human papillomavirus vaccine, L1 type 16, 18 6 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 6 Papillomavirus Vaccines 3 Vaccines 2 Engerix-B 2 adacel 1 Vaccines, Synthetic 1 Tetanus Toxoid 1 Methods 1 Hepatitis A Vaccines 1 Educational Status 1 Early Intervention, Educational 1 Diphtheria-Tetanus-acellular Pertussis Vaccines 1 Diphtheria Toxoid 1 Clinical Protocols 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03180034 2025-09-04

ESCUDDO

National Cancer Institute (NCI)

Phase 4 Active not recruiting

27,945 enrolled

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡